comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 09:44:34 - browse：7

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： As AI regulations shape up, health tech startups beg for clarity

Wikipedia

leisure time

WSS

In 'major milestone,' FDA approves first cell therapy for solid tumors

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

New study raises questions about niacin and heart health

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Cosmetics set for new safety regulation. Why the industry is on board

Custom gene therapy hints at new path for rare disease treatments

focus

comprehensive

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden tests positive for Covid

Walensky prepares to leave CDC — and Congress — behind

AI can’t replace a physician’s gut feeling

Apple is now the first public company to be valued at $3 trillion

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Guidelines to prevent youth baseball injuries need more muscle

As digital health tech proliferates, a new institute aims to cut through hype

Medical records are filled with copy

Secretariat’s lessons for human medicine

hotspot

Obamacare plans could cover weight loss drugs

MD Anderson's Padmanee Sharma responds to research credit suit

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare has a new plan to address drug shortages

Medicare Advantage enrollment grows 7.1% to 33.4 million people

hotspot

Wikipedia

leisure time

focus